Ambu A/S (AMBU-B.CO) Stock Analysis & Winston Score
Ambu is a Danish medical device company that makes tools doctors use to look inside patients' bodies and to help people breathe during emergencies. Its main products are single-use endoscopes — thin, flexible cameras used in hospitals — along with breathing masks, bags, and monitoring equipment. Ambu is best known for pioneering the disposable endoscope, which hospitals use instead of reusable scopes that need to be cleaned between patients. Ambu earns money by selling its devices directly to hospitals and clinics, mostly on a per-procedure basis as doctors use and discard single-use products. The company operates globally, with strong sales in Europe and North America, and generates roughly $600–700 million in annual revenue. Its main competitive advantage is its early lead in single-use endoscopy, but it faces growing competition from larger device makers entering the same market. The key growth driver is continued hospital adoption of disposable endoscopes, while pricing pressure and competition remain the central risks.
Winston Score: 63/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Mixed (13/30)
- Growth: Strong (15/20)
- Cash Flow: Strong (8/10)
- Stability: Exceptional (10/10)
- Valuation: Good (6/10)
- Ownership: Good (10/15)
Key Facts
Price: $69.10
Market Cap: $18.4B
Sector: Healthcare
Industry: Medical - Devices
Exchange: NASDAQ Copenhagen


